Power Law company profile

Foundation Medicine

Biotech & Life Sciences · Boston, United States · Founded 2010 · IPO 2013 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$5.30B

Market cap · 2026

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease

Investors

7 investors on Foundation Medicine's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Kleiner Perkins

Third Rock Ventures

Series B+ 5 investors entered at this stage

Roche Venture Fund

Redmile Group

Bill Gates

Casdin Capital

Evan Jones

Global footprint

Where Foundation Medicine has talent and traffic

Workforce by country

🇺🇸 United States · Boston HQ

Book a demo for the full country breakdown

Web traffic by country

69K monthly visits
across markets

🇺🇸 United States64.1%

🇮🇳 India14.3%

🇨🇦 Canada4.3%

🏳️ Russian Federation2.9%

🏳️ Korea2.8%

Top 5 markets shown

Capital deployed

Foundation Medicine's 3 investments and acquisitions.

Every disclosed deal where Foundation Medicine appeared as a backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Foundation Medicine's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount

By stageCount

By periodCount

02 · Portfolio market map

Foundation Medicine's portfolio, mapped.

Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

Stage

Period

3 of 3 deals

Sentiment on X

What X is saying about Foundation Medicine

An AI-synthesized read of the highest-engagement posts about Foundation Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Foundation Medicine on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles